Humain Ventures Fund I, LP
Open, writing first checksEmerging manager
Open: first sale May 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $5.3M to $10M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
Humain Ventures backs founders building therapeutics, prevention, and human health. It favors Tech Bio, where AI and programmable biology change how drugs are built, and prevention-first health systems. It also backs consumer-owned health data through wearables and continuous biosensing.Inferred from the firm's website
02 · Initial check
$53K to $167K (estimated from fund size)
Estimated from Form D: $5.3M sold of a $10M target
03 · Who to approach
Named on this fund's Form D
- Aneil Mallavarapu, Managing Partner of the Manager of the General Partner of the Fund
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideHumain Ventures backs founders building the future of therapeutics, prevention, and human health.
Humain Ventures backs founders building the future of therapeutics, prevention, and human health.
https://www.humain.vc/
06 · Sources
Last verified: Oct 28, 2026